Bispecific Designed Ankyrin Repeat Proteins (DARPins) Targeting Epidermal Growth Factor Receptor Inhibit A431 Cell Proliferation and Receptor Recycling
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bispecific Designed Ankyrin Repeat Proteins (DARPins) Targeting Epidermal Growth Factor Receptor Inhibit A431 Cell Proliferation and Receptor Recycling
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 48, Pages 41273-41285
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2011-10-07
DOI
10.1074/jbc.m111.293266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DARPins and other repeat protein scaffolds: advances in engineering and applications
- (2011) Ykelien L Boersma et al. CURRENT OPINION IN BIOTECHNOLOGY
- Non-immunoglobulin based protein scaffolds
- (2011) John Löfblom et al. CURRENT OPINION IN BIOTECHNOLOGY
- A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
- (2011) Rob C. Roovers et al. INTERNATIONAL JOURNAL OF CANCER
- Enhanced EGFR inhibition and distinct epitope recognition by EGFR antagonistic MABS C225 and 425
- (2010) Vishal Kamat et al. CANCER BIOLOGY & THERAPY
- Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size
- (2010) C. Zahnd et al. CANCER RESEARCH
- Sym004: A Novel Synergistic Anti-Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy
- (2010) M. W. Pedersen et al. CANCER RESEARCH
- A Novel Fusion Toxin Derived from an EpCAM-Specific Designed Ankyrin Repeat Protein Has Potent Antitumor Activity
- (2010) P. Martin-Killias et al. CLINICAL CANCER RESEARCH
- Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling
- (2010) J. B. Spangler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor
- (2009) Mari Maegawa et al. CANCER SCIENCE
- ErbB receptors and signaling pathways in cancer
- (2009) Nancy E Hynes et al. CURRENT OPINION IN CELL BIOLOGY
- Different antiproliferative effects of matuzumab and cetuximab in A431 cells are associated with persistent activity of the MAPK pathway
- (2009) Debora Dummer Meira et al. EUROPEAN JOURNAL OF CANCER
- A novel anti-EGFR monoclonal antibody inhibiting tumor cell growth by recognizing different epitopes from cetuximab
- (2009) Kwang-Won Hong et al. JOURNAL OF BIOTECHNOLOGY
- EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins
- (2009) J. Winkler et al. MOLECULAR CANCER THERAPEUTICS
- Antibodies specifically targeting a locally misfolded region of tumor associated EGFR
- (2009) T. P. J. Garrett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization
- (2008) Judith Schmiedel et al. CANCER CELL
- Membrane-anchored growth factors, the epidermal growth factor family: Beyond receptor ligands
- (2008) Shigeki Higashiyama et al. CANCER SCIENCE
- Interaction of antibodies with ErbB receptor extracellular regions
- (2008) Karl R. Schmitz et al. EXPERIMENTAL CELL RESEARCH
- EGFR family: Structure physiology signalling and therapeutic targets†
- (2008) Antony W. Burgess GROWTH FACTORS
- ErbB-directed immunotherapy: Antibodies in current practice and promising new agents
- (2008) Elza Friedländer et al. IMMUNOLOGY LETTERS
- ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium
- (2008) Stephen J. Fuller et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage Display
- (2008) Daniel Steiner et al. JOURNAL OF MOLECULAR BIOLOGY
- Structural Basis for EGF Receptor Inhibition by the Therapeutic Antibody IMC-11F8
- (2008) Shiqing Li et al. STRUCTURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started